Studies investigating the relationship between METRNL and cancer show that METRNL has a protumor effect in pancreatic cancer and emphasize that it is diagnostically valuable for bladder cancer, basal cell cancer of the skin and malignant mesothelioma [12,13-15]. This evidence concerns the gene METRNL and familial pancreatic carcinoma.